All episodes
We Can See Tumor Heterogeneity. Now What? We Ask Cathy Smith, UCSF
Hallelujah! A Universal Flu Preventative and Therapy with Jeff Stein, Cidara
'The Movement:' John Cumbers Previews the Rapidly Growing SynBioBeta 2019
Anya Prince on Our Current Vulnerability to Genetic Discrimination
Do Long Reads Hold Answers for Alzheimer’s? with Mark Ebbert, Mayo
With Nanopore Sensing Beyond Sequencing, Ontera Takes 'Lab' to the Field
Mark Chaisson on Two New Structural Variation Papers
Early Cancer Detection: Is This Company Ahead of Grail?
June 2019 Review with Nathan and Laura: Gene Patents, Grail, Dr. Lynch
Should Genomic Screening Be Standard of Care? with Adam Buchanan, Geisinger
May 2019 Review with Nathan and Laura: Gene Therapies, DTC Shifts, Gender and Sports
Toward the Human Pan Genome with Adam Phillippy, NHGRI
Laura Hercher on the DTC Genetic Testing Landscape
Arcadia Biosciences Pivots to Bring Us Non-GMO, High Fiber GoodWheat and Better Cannabis
April 2019 Review with Nathan and Laura: uBiome Raided by FBI, PRS for Obesity, and a Gene Therapy Cure
The Era of the Social Genome with Rodrigo Martinez, Veritas Genetics
Reassessing Alzheimer’s with Larry Goldstein, UCSD
Family Surprises Care of the Home DNA Test with Brianne Kirkpatrick
March 2019 with Nathan and Laura: Old Envelopes, Wooly Mammoth DNA, and the Night King
Single Cell Analysis Shows Important New Detail in Key Clinical Study of AML: Koichi Takahashi, MD Anderson
Science Communication in a Post Fact World with Erik Clausen
February 2019 Review with Nathan and Laura: Family Surprises, IQ Profiling, and Chinese Surveillance
Heretic No Longer? Meet Michael Joyner, Precision Medicine’s Critic-in-Chief
The Internet of Biology Revolution-For Real This Time, with Brett Goldsmith, Cardea
January 2019 Review with Nathan and Laura: Cloning, CRISPRing, DTC, and Paleogenomic Overreach
Cara O'Neill of the Cure Sanfilippo Foundation Tells Her Story
PregSource: The NIH’s Crowdsourcing Project for Pregnancy Data with Caroline Signore
Meet Christian, Janos, and the New World of 3D Oncology
Has Computational Modeling for Cancer Genomics "Arrived?" with Shirley Liu, Dana Farber
Amy Harmon of the NYT on Race & Genetics, Women in Science
CRISPR or Not, You Can't Genetically Enhance Humans, Says Sci-Fi Author Kim Stanley Robinson
The New World of Infectious Disease Diagnosis: Out in the Field with David Hong of Karius
California Life Science Industry Steps to New Heights - the 2019 Edition with Sara Radcliffe
Nathan and Laura on CRISPRed Babies and Other November 2018 Stories
Ellen Matloff on a New Digital Genetic Counseling Product for DTC Customers
Connecting the Dots for a Community of Rare Disease Patients: Terri Klein, MPS Society
Keith Robison and Shawn Baker on Illumina Buyout of PacBio
October 2018 Review with Nathan and Laura: ASHG Does Race, Parents Do Gene Therapy, Unsung Demons
A Point-of-Care CBC Test Based on a Few Drops of Blood—Is This the Real Thing? with Danny Levner, Sight Diagnostics
It’s a Gold Rush in Single Cell Genomics, Says Joachim Schultze, U of Bonn
A Market Solution for Biospecimen Quality Standards with Matt McLoughlin, Scientist.com
September 2018 with Nathan and Laura: Studying the Same Genes and the Matt Fender Story
Single Cell Sequencing Tailor Made for Nephrology, Says Vivek Bhalla, Stanford
It’s the Social Factors, Stupid! Lisa Suennen on Healthcare, Her Career, Digital Health Investing, and . . . Just Being Herself
Concerned About DTC Test Quality? Ask Two Questions, Says Daryl Pritchard, PMC
August 2018 Review with Nathan and Laura: The polygenic month
An International Perspective on How to Improve Biobanking with Kirstin Goldring
A Seqster Preview with Founder Ardy Arianpour
Detective Stories from the Genomic War Room with Ramesh Hariharan
Should Biobanking Come Under CLIA? Shannon McCall, Duke
Pharma Stepping Up, Footing the Bill for Genetic Testing & Counseling: Jordanna Mora, Alnylam
Are We Asking Too Much of Genomics in Cancer Research? Tony Letai, Dana Farber
I Won’t Rest Until We Have Quality Standards in Place for Biospecimens: Carolyn Compton, ASU
May 2018 with Nathan and Laura: The Free Exome, California Database, and Mosaicism
Has Diagnostic Testing Plateaued? Alka Chaubey, Greenwood Genetic Center
A New Way for DTC? Nathan Pearson, Root Deep Insight
Genetic Testing in the Age of Trump: Hank Greely, Stanford
Genetic Testing is Dead, Long Live Genetic Testing: Sean George of Invitae
April 2018 with Nathan and Laura: Golden State Killer and the Cancer Prediction Space
Liquid Biopsy for Infectious Disease with Mickey Kertesz, Karius
Nanopore Sequencing and the Future of Cancer Research with Chia-Lin Wei, JAX
A New Method for Long Reads: Hanlee Ji of Stanford on Cancer Genomics Tech 2018
March 2018 in Genomics with Nathan & Laura: DTC BRCA and Revisiting All of Us
With More Tools in the Box, Lon Cardon Says We’re in a New Age of Drug Development
Personalized Medicine in the Trump Era with Edward Abrahams
Eric Schadt and Sema4 Try the Consumer Model with Newborn Screening Panel
February 2018 in Genomics with Nathan & Laura: 23andMe Goes for the Gold, Trump Year One
State of Sequencing 2018 with Keith Robison, Omics! Omics! Blogger
Direct RNA-Seq Project Shows Nanopore Sequencing Can Reveal New Insights into Basic Biology: Winston Timp, JHU
January 2018 Review Show with Nathan and Laura: CRISPR vs The Immune System, Biotech Math, and MinION's Big Test
Going Beyond the Liver with RNAi: Chris Anzalone of Arrowhead Pharma
Vice Chancellor Keith Yamamoto on UCSF’s Role in Medicine Today
The Global Business of Reproductive Genetic Testing with Gary Harton, Igenomix
The State of Genomics 2018 with Nathan, Laura, and Misha
Sharon Begley of STAT News
A New “Middle Way” for Genomics, with Physical Chemist, Yuval Ebenstein
Sara Demy on Biotech CEOs
November 2017 with Nathan and Laura: The Stem Cell Story We’ve All Been Waiting For and a Sea Change for DTC Testing
Seattle Startup Takes Precision Oncology to the Next Step: Carla Grandori, CEO, SEngine
Immuno Oncology 2017: Looking Back, Looking Forward with Rachel Laing and Olivier Lesueur
Huh? 30 Million Americans Have a Rare Disease? Howard Jacob on the State of Clinical Sequencing
With their Own Manufacturing Facility, Seattle Children’s Goes Big into CAR-T, Rare Disease
With Immuno Oncology Comes a New Focus on Rare Cells
We've Become Too Single Variant Centric, Says Deanna Church on Genome Analysis
Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai
September 2017 with Nathan and Laura: Venter Blunder, RNAi Returns, and Monthly Science Moments
Charting the Dark Matter of Cancer Genomes with Jim Broach
Why Childhood Cancers Need Their Own Gene Panel: Tim Triche
Exploring the Exome and the Future of Genomics with Jay Shendure
August 2017 Review with Nathan and Laura: CAR-T Cashes In, Embryos Edited in US, and the Invitae Incident
The First In-Human Gene Editing Trial in the U.S. - And It’s Not with CRISPR
Thermo, Pfizer, and Novartis Pull Off a First for NGS in Lung Cancer
Making Genetic Testing Mainstream Medicine with Sean George, Invitae
Need Better Standards for Your Clinical Assays? NIST Can Help
Turning on Your DNA with Justin Kao, Helix
Will This New Nano Technology Be the Microarray of Genomic Structural Variation? Barrett Bready, Nabsys
George Church on What Comes After CRISPR
Is CRISPR Controversy Science or Spin? June 2017 Review with Nathan and Laura
We Need a Google Maps for Metagenomics, Says Rob Knight, UCSD
Move Over PDL1: New Test Combo Adds RNAseq to Better Track Immune Escape